Production of recombinant protein in Pichia pastoris by fermentation

Nature Protocols

Volumn 1, Issue 2, 2006, Pages 1006-1021

  Tolner, Berend ^a   Smith, Lisa ^a   Begent, Richard H J ^a   Chester, Kerry A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN;

ARTICLE; BIOREACTOR; FERMENTATION; GENE EXPRESSION; METABOLISM; PHYSIOLOGY; PICHIA;

BIOREACTORS; FERMENTATION; GENE EXPRESSION; PICHIA; RECOMBINANT PROTEINS;

EID: 33845593592     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2006.126     Document Type: Article

References (28)

1. Cregg, J.M., Cereghino, J.L., Shi, J. & Higgins, D.R. Recombinant protein expression in Pichia pastoris. Mol. Biotechnol. 16, 23-52 (2000).
2. Daly, R. & Hearn, M.T. Expression of heterologous proteins in Pichia pastoris: A useful experimental tool in protein engineering and production. J. Mol. Recognit. 18, 119-138 (2005).
3. Macauley-Patrick, S., Fazenda, M.L., McNeil, B. & Harvey, L.M. Heterologous protein production using the Pichia pastoris expression system. Yeast 22, 249-270 (2005).
4. Baez, J., Olsen, D. & Polarek, J.W. Recombinant microbial systems for the production of human collagen and gelatin. Appl. Microbiol. Biotechnol. 69, 245-252 (2005).
5. Zhang, W., Bevins, M.A., Plantz, B.A., Smith, L.A. & Meagher, M.M. Modeling Pichia pastoris growth on methanol and optimizing the production of a recombinant protein, the heavy-chain fragment C of botulinum neurotoxin, serotype A. Biotechnol. Bioeng. 70, 1-8 (2000).
6. Tolner, B., Smith, L., Begent, R.H.J. & Chester, K.A. Expanded bed adsorption immobilized metal affinity chromatography. Nat. Protocols (in press).
7. Lee, Y.C. Structural and interaction studies of an anti-carcinoembryonic antigen single-chain Fv antibody: Application to molecular design for cancer targeting. Ph.D. Thesis, University of London, (2003).
8. Sainz-Pastor, N. et al. Deglycosylation to obtain stable and homogeneous Pichia pastoris-expressed N-A1 domains of carcinoembryonic antigen. Int. J. Biol. Macromol. (in press)
9. Sharma, S.K. et al. Sustained tumor regression of human colorectal cancer xenografts using a multifunctional mannosylated fusion protein in antibody-directed enzyme prodrug therapy. Clin. Cancer Res. 11 814-825 (2005).
10. Francis, R.J. et al. Radiolabelling of glycosylated MFE-23::CPG2 fusion protein (MFECP1) with Tc-99m for quantitation of tumour antibody-enzyme localisation in antibody-directed enzyme pro-drug therapy (ADEPT). European J. Nuclear Med. Mol. Imaging 31, 1090-1096 (2004).
11. Mayer, A. et al. A phase I study of single administration of antibody-directed enzyme prodrug therapy (ADEPT) with the recombinant anti-CEA antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug. Clin. Cancer Res. (in press).
12. Bhatia, J. et al. Catalytic activity of an in vivo tumor targeted anti-CEA scFv::Carboxypeptidase G2 fusion protein. Int. J. Cancer 85, 571-577 (2000).
13. Bretthauer, R.K. & Castellino, F.J. Glycosylation of Pichia pastoris derived proteins. Biotechnol. Appl. Biochem. 30, 193-200 (1999).
14. Trimble, R.B., Atkinson, P.H., Tschopp, J.F., Townsend, R.R. & Maley, F. Structure of oligosaccharides on Saccharomyces SUC2 invertase secreted by the methylotrophic yeast. Pichia pastoris. J. Biol. Chem. 266, 22807-22817 (1991).
15. Medzihradszky, K. F. et al. Glycoforms obtained by expression in Pichia pastoris improve cancer targeting potential of a recombinant antibody-enzyme fusion protein. Glycobiology 14, 27-37 (2004).
16. Gemgross, T.U. Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. Nat. Biotechnol. 22, 1409-1414 (2004).
17. Malkin, E.M. et al. Phase 1 clinical trial of apical membrane antigen 1: An asexual blood-stage vaccine for Plasmodium falciparum malaria. Infect. Immun. 73, 3677-3685 (2005).
18. Herbst, R.S. et al. Phase I study of recombinant human endostatin in patients with advanced solid tumors. J. Clin. Oncol. 20, 3792-3803 (2002).
19. Kobayashi, K. Summary of recombinant human serum albumin development. Biologicals 34, 55-59 (2006).
20. Li, H. et al. Optimization of humanized IgGs in glycoengineered Pichia pastoris. Nat. Biotechnol. 24, 210-215 (2006).
21. Jahic, M., Gustavsson, M., Jansen, A.K., Martinelle, M. & Enfors, S.O. Analysis and control of proteolysis of a fusion protein in Pichia pastoris fed-batch processes. J. Biotechnol. 102, 45-53 (2003).
22. Sinha, J., Plantz, B.A., Inan, M. & Meagher, M.M. Causes of proteolytic degradation of secreted recombinant proteins produced in methylotrophic yeast Pichia pastoris: Case study with recombinant ovine interferon-τ. Biotechnol. Bioeng. 89, 102-112 (2005).
23. Kobayashi, K. et al. High-level expression of recombinant human serum albumin from the methylotrophic yeast Pichia pastoris with minimal protease production and activation. J. Biosci. Bioeng. 89, 55-61 (2000).
24. Wang, J. et al. Improved yield of recombinant merozoite surface protein 3 (MSP3) from Pichia pastoris using chemically defined media. Biotechnol. Bioeng. 90, 838-847 (2005).
25. Werten, M.W. et al. High-yield secretion of recombinant gelatins by Pichia pastoris. Yeast 15, 1087-1096 (1999).
26. Li, Z.J. et al. Low-temperature increases the yield of biologically active herring antifreeze protein in Pichia pastoris. Protein Expr. Purif. 21, 438-445 (2001).
27. Vervecken, W. et al. In vivo synthesis of mammalian-like, hybrid-type N-glycans in Pichia pastoris. Appl. Environ. Microbiol. 70, 2639-2646 (2004).
28. O'Leary, J.M. et al. Identification and removal of O-linked and non-covalently linked sugars from recombinant protein produced using Pichia pastoris. Protein Expr. Purif. 38, 217-227 (2004).